Senior insider sale
Chief Executive Officer at MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$4.16M
160.70K shares
CONGLETON JON plans to sell 160.70K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $4.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of Restricted Stock Unit Awards
Granted as part of issuer equity compensation plan
Vesting of Restricted Stock Unit Awards
Granted as part of issuer equity compensation plan
Vesting of Restricted Stock Unit Awards
Granted as part of issuer equity compensation plan
Vesting of Restricted Stock Unit Awards
Granted as part of issuer equity compensation plan
Vesting of Restricted Stock Unit Awards
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/10/2026 | Vesting of Restricted Stock Unit Awards Granted as part of issuer equity compensation plan | 10.25K | — |
10/10/2025 | Vesting of Restricted Stock Unit Awards Granted as part of issuer equity compensation plan | 20.85K | — |
7/10/2025 | Vesting of Restricted Stock Unit Awards Granted as part of issuer equity compensation plan | 20.07K | — |
4/10/2025 | Vesting of Restricted Stock Unit Awards Granted as part of issuer equity compensation plan | 20.64K | — |
1/10/2025 | Vesting of Restricted Stock Unit Awards Granted as part of issuer equity compensation plan | 3.19K | — |
| Total | 75K | ||
Completed
Units to sell
10.70K
Market value
$291.4K
Units to sell
75K
Market value
$1.96M
Planned — Approximate Date
Units to sell
75K
Market value
$1.91M
Units
160.70K
Value
$4.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/13/2026 | 10.70K | $291.4K | — | Completed |
6/30/2026 | 75K | $1.96M | — | Completed |
| Planned — Approximate Date | ||||
9/30/2026 | 75K | $1.91M | NASDAQ | Planned |
| Total | 160.70K | $4.16M | ||